The milestone comes two months after the company surpassed 500 procedures with the devices, according to a news release. Procedure volume jumped more than 60 percent in the first quarter of 2023 compared to the fourth quarter of 2022.
Prodisc C Vivo and Prodisc C SK were launched in September. Centinel Spine’s Prodisc portfolio has seen more than 225,000 global implantations.
